SARS-CoV-2 (2019-nCoV) is a positive-sense single-stranded RNA virus, and it is contagious in humans. From a taxonomic perspective, SARS-CoV-2 is classied as a strain of the species named severe acute respiratory syndrome-related Coronavirus (or SARSr CoV). SARS-CoV-2 IgM/IgG Detection SARS-CoV-2 produces specic antibodies against pathogens after rst infection in the human body. The earliest antibody produced is IgM, which is secreted directly by the B-cell surface receptor. The B cells that produce IgM enter the lymph nodes, receive stimulation from T cells and antigen-carrying cells at the...

NAT Negative but suspected patients should test IgG / IgM for SARS-CoV-2 Detection IgM (+) / IgG (-): Suspected acute infection, test again 1 week later IgM (-) / IgG (+): IgG false positive, or past infection, pay attention to IgG titer, if IgG increases 4 times later, it might be recent infection or acute infection 1 week later: IgM (+) / IgG (-), might be false positive, keep monitor treatment results, if a patient is positive for IgM after recovery, then it is false positive for IgM 1 week later: IgM (+) /IgG (+), might be acute infection IgM (+) / IgG (+): Suspected acute infection, test...

Anti-interference to Legionella pneumococcal, mycoplasma pneumonia, chlamydia pneumonia, adenoviruses, respiratory syncytial viruses, influenza A, influenza B and para-flu viruses 1,2 and 3, etc. Comprehensive Solution High Specificity With strong social responsibility and professional R&D team, we made independent development of raw materials and stable supply for new assays within 1 month. Up to 1200 T/H can be achieved by our iFlash series CLIA analyzers (iFLash 1800: 180 T/H; iFlash 3000: 300 T/H, iModule: up to 1200 T/H). Based on 2000+ sample evaluations in 20+ Chinese Class A hospitals,...